P21709 (EPHA1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 155.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Ephrin type-A receptor 1 Short name=hEpha1 EC=2.7.10.1 Alternative name(s): EPH tyrosine kinase EPH tyrosine kinase 1 Erythropoietin-producing hepatoma receptor Tyrosine-protein kinase receptor EPH | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 976 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Binds with a low affinity EFNA3 and EFNA4 and with a high affinity to EFNA1 which most probably constitutes its cognate/functional ligand. Upon activation by EFNA1 induces cell attachment to the extracellular matrix inhibiting cell spreading and motility through regulation of ILK and downstream RHOA and RAC. Plays also a role in angiogenesis and regulates cell proliferation. May play a role in apoptosis. Ref.9 Ref.10 Ref.11 |
| Catalytic activity | ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate. |
| Subunit structure | Homodimer. Forms a signaling complex with LCK; PTK2B/PYK2 and PI3-kinase upon activation by EFNA1; regulates T-lymphocytes migration. Interacts (via SAM domain) with ILK (via ANK repeats); stimulated by EFNA1 but independent of the kinase activity of EPHA1. Interacts (kinase activity-dependent) with PTK2/FAK1. Ref.9 Ref.10 Ref.13 |
| Subcellular location | |
| Tissue specificity | Overexpressed in several carcinomas. |
| Post-translational modification | Phosphorylated. Autophosphorylation is stimulated by its ligand EFNA1. Ref.10 |
| Sequence similarities | Belongs to the protein kinase superfamily. Tyr protein kinase family. Ephrin receptor subfamily. Contains 1 Eph LBD (Eph ligand-binding) domain. Contains 2 fibronectin type-III domains. Contains 1 protein kinase domain. Contains 1 SAM (sterile alpha motif) domain. |
| Sequence caution | The sequence AAA36747.1 differs from that shown. Reason: Frameshift at positions 582, 595 and 601. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 25 | 25 | Potential | |||||||||||||||||||||
| Chain | 26 – 976 | 951 | Ephrin type-A receptor 1 | PRO_0000016798 | ||||||||||||||||||||
Regions | ||||||||||||||||||||||||
| Topological domain | 26 – 547 | 522 | Extracellular Potential | |||||||||||||||||||||
| Transmembrane | 548 – 568 | 21 | Helical; Potential | |||||||||||||||||||||
| Topological domain | 569 – 976 | 408 | Cytoplasmic Potential | |||||||||||||||||||||
| Domain | 27 – 209 | 183 | Eph LBD | |||||||||||||||||||||
| Domain | 332 – 437 | 106 | Fibronectin type-III 1 | |||||||||||||||||||||
| Domain | 446 – 535 | 90 | Fibronectin type-III 2 | |||||||||||||||||||||
| Domain | 624 – 884 | 261 | Protein kinase | |||||||||||||||||||||
| Domain | 913 – 976 | 64 | SAM | |||||||||||||||||||||
| Nucleotide binding | 630 – 638 | 9 | ATP By similarity | |||||||||||||||||||||
| Motif | 974 – 976 | 3 | PDZ-binding Potential | |||||||||||||||||||||
| Compositional bias | 191 – 329 | 139 | Cys-rich | |||||||||||||||||||||
Sites | ||||||||||||||||||||||||
| Active site | 749 | 1 | Proton acceptor By similarity | |||||||||||||||||||||
| Binding site | 656 | 1 | ATP By similarity | |||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||
| Modified residue | 599 | 1 | Phosphotyrosine; by autocatalysis Potential | |||||||||||||||||||||
| Modified residue | 605 | 1 | Phosphotyrosine; by autocatalysis Potential | |||||||||||||||||||||
| Modified residue | 781 | 1 | Phosphotyrosine; by autocatalysis Potential | |||||||||||||||||||||
| Modified residue | 906 | 1 | Phosphoserine Ref.12 | |||||||||||||||||||||
| Modified residue | 910 | 1 | Phosphoserine Ref.12 | |||||||||||||||||||||
| Modified residue | 930 | 1 | Phosphotyrosine; by autocatalysis Potential | |||||||||||||||||||||
| Glycosylation | 414 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||
| Natural variant | 160 | 1 | V → A. Ref.1 Ref.2 Ref.4 Ref.5 Ref.6 Ref.15 Corresponds to variant rs4725617 [ dbSNP | Ensembl ]. | VAR_028265 | ||||||||||||||||||||
| Natural variant | 351 | 1 | R → C. Ref.15 Corresponds to variant rs56006153 [ dbSNP | Ensembl ]. | VAR_042115 | ||||||||||||||||||||
| Natural variant | 492 | 1 | R → Q. Ref.15 Corresponds to variant rs11768549 [ dbSNP | Ensembl ]. | VAR_028266 | ||||||||||||||||||||
| Natural variant | 575 | 1 | R → Q. Ref.15 Corresponds to variant rs35719334 [ dbSNP | Ensembl ]. | VAR_042116 | ||||||||||||||||||||
| Natural variant | 585 | 1 | A → T. Ref.15 Corresponds to variant rs34178823 [ dbSNP | Ensembl ]. | VAR_042117 | ||||||||||||||||||||
| Natural variant | 697 | 1 | P → L. Ref.15 Corresponds to variant rs34372369 [ dbSNP | Ensembl ]. | VAR_042118 | ||||||||||||||||||||
| Natural variant | 703 | 1 | E → K in a breast pleomorphic lobular carcinoma sample; somatic mutation. Ref.15 | VAR_042119 | ||||||||||||||||||||
| Natural variant | 807 | 1 | S → R. Ref.15 Corresponds to variant rs56244405 [ dbSNP | Ensembl ]. | VAR_042120 | ||||||||||||||||||||
| Natural variant | 900 | 1 | M → V. Ref.1 Ref.2 Ref.4 Ref.5 Ref.6 Ref.7 Ref.15 Ref.16 Corresponds to variant rs6967117 [ dbSNP | Ensembl ]. | VAR_028267 | ||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||
| Sequence conflict | 398 | 1 | G → A in AAD43440. Ref.2 | |||||||||||||||||||||
| Sequence conflict | 398 | 1 | G → A in CAA81796. Ref.7 | |||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||
| Beta strand | 538 – 540 | 3 | ||||||||||||||||||||||
| Helix | 545 – 570 | 26 | ||||||||||||||||||||||
| Helix | 918 – 924 | 7 | ||||||||||||||||||||||
| Helix | 928 – 930 | 3 | ||||||||||||||||||||||
| Helix | 931 – 936 | 6 | ||||||||||||||||||||||
| Helix | 942 – 945 | 4 | ||||||||||||||||||||||
| Helix | 950 – 955 | 6 | ||||||||||||||||||||||
| Helix | 961 – 973 | 13 | ||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A novel putative tyrosine kinase receptor encoded by the eph gene." Hirai H., Maru Y., Hagiwara K., Nishida J., Takaku F. Science 238:1717-1720(1987) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANTS ALA-160 AND VAL-900. |
| [2] | "Genomic structure of the EPHA1 receptor tyrosine kinase gene." Owshalimpur D., Kelley M.J. Mol. Cell. Probes 13:169-173(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS ALA-160 AND VAL-900. |
| [3] | "The DNA sequence of human chromosome 7." Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H., Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A., Delehaunty K.D., Miner T.L. Wilson R.K.Nature 424:157-164(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "Human chromosome 7: DNA sequence and biology." Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K., Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R., Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A., Kanematsu E., Gentles S. Tsui L.-C.Science 300:767-772(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANTS ALA-160 AND VAL-900. |
| [5] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], VARIANTS ALA-160 AND VAL-900. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANTS ALA-160 AND VAL-900. Tissue: Brain. |
| [7] | "An EGFR/eph chimeric receptor possesses ligand stimulated tyrosine kinase activity and promotes cell growth." Tuzi N.L. Submitted (MAY-1994) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 286-976, VARIANT VAL-900. Tissue: Placenta. |
| [8] | "Unified nomenclature for Eph family receptors and their ligands, the ephrins." Eph nomenclature committee Cell 90:403-404(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NOMENCLATURE. |
| [9] | "Ephrin-A1 stimulates migration of CD8+CCR7+ T lymphocytes." Hjorthaug H.S., Aasheim H.C. Eur. J. Immunol. 37:2326-2336(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN MIGRATION OF T-LYMPHOCYTES, INTERACTION WITH LCK; PTK2B/PYK2 AND PI3-KINASE. |
| [10] | "EphA1 interacts with integrin-linked kinase and regulates cell morphology and motility." Yamazaki T., Masuda J., Omori T., Usui R., Akiyama H., Maru Y. J. Cell Sci. 122:243-255(2009) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN CELL SPREADING, FUNCTION IN CELL MIGRATION, AUTOPHOSPHORYLATION, SUBCELLULAR LOCATION, INTERACTION WITH PTK2/FAK1 AND ILK. |
| [11] | "EphA1 receptor silencing by small interfering RNA has antiangiogenic and antitumor efficacy in hepatocellular carcinoma." Chen G., Wang Y., Zhou M., Shi H., Yu Z., Zhu Y., Yu F. Oncol. Rep. 23:563-570(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN ANGIOGENESIS, FUNCTION IN CELL PROLIFERATION. |
| [12] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-906 AND SER-910, MASS SPECTROMETRY. |
| [13] | "Spatial structure and pH-dependent conformational diversity of dimeric transmembrane domain of the receptor tyrosine kinase EphA1." Bocharov E.V., Mayzel M.L., Volynsky P.E., Goncharuk M.V., Ermolyuk Y.S., Schulga A.A., Artemenko E.O., Efremov R.G., Arseniev A.S. J. Biol. Chem. 283:29385-29395(2008) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 536-573, HOMODIMERIZATION. |
| [14] | "Sam domain of human ephrin type-a receptor 1 (epha1)." Structural genomics consortium (SGC) Submitted (JUN-2009) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 911-974. |
| [15] | "Patterns of somatic mutation in human cancer genomes." Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. Stratton M.R.Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] ALA-160; CYS-351; GLN-492; GLN-575; THR-585; LEU-697; LYS-703; ARG-807 AND VAL-900. |
| [16] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] VAL-900, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | M18391 mRNA. Translation: AAA36747.1. Frameshift. AF101171 AF101170 Genomic DNA. Translation: AAD43440.1.AC092214 Genomic DNA. Translation: AAS07458.1. CH236959 Genomic DNA. Translation: EAL23789.1. CH471198 Genomic DNA. Translation: EAW51846.1. CH471198 Genomic DNA. Translation: EAW51847.1. BC130291 mRNA. Translation: AAI30292.1. Z27409 mRNA. Translation: CAA81796.1. | ||||||||||||||||||||||||||||||
| IPI | IPI00294250. | ||||||||||||||||||||||||||||||
| PIR | A34076. | ||||||||||||||||||||||||||||||
| RefSeq | NP_005223.4. NM_005232.4. | ||||||||||||||||||||||||||||||
| UniGene | Hs.89839. | ||||||||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||||||||
| ProteinModelPortal | P21709. | ||||||||||||||||||||||||||||||
| SMR | P21709. Positions 24-893, 911-974. | ||||||||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||||||||
| IntAct | P21709. 1 interaction. | ||||||||||||||||||||||||||||||
| STRING | 9606.ENSP00000275815. | ||||||||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||||||||
| PhosphoSite | P21709. | ||||||||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||||||||
| DMDM | 47117832. | ||||||||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||||||||
| PaxDb | P21709. | ||||||||||||||||||||||||||||||
| PRIDE | P21709. | ||||||||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||||||||
| DNASU | 2041. | ||||||||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||||||||
| Ensembl | ENST00000275815; ENSP00000275815; ENSG00000146904. | ||||||||||||||||||||||||||||||
| GeneID | 2041. | ||||||||||||||||||||||||||||||
| KEGG | hsa:2041. | ||||||||||||||||||||||||||||||
| UCSC | uc003wcz.3. human. | ||||||||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||||||||
| CTD | 2041. | ||||||||||||||||||||||||||||||
| GeneCards | GC07M143087. | ||||||||||||||||||||||||||||||
| H-InvDB | HIX0033699. | ||||||||||||||||||||||||||||||
| HGNC | HGNC:3385. EPHA1. | ||||||||||||||||||||||||||||||
| HPA | CAB026144. | ||||||||||||||||||||||||||||||
| MIM | 179610. gene. | ||||||||||||||||||||||||||||||
| neXtProt | NX_P21709. | ||||||||||||||||||||||||||||||
| PharmGKB | PA27817. | ||||||||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||||||||
| eggNOG | COG0515. | ||||||||||||||||||||||||||||||
| HOGENOM | HOG000233856. | ||||||||||||||||||||||||||||||
| HOVERGEN | HBG062180. | ||||||||||||||||||||||||||||||
| InParanoid | P21709. | ||||||||||||||||||||||||||||||
| KO | K05102. | ||||||||||||||||||||||||||||||
| OMA | GWSEVQQ. | ||||||||||||||||||||||||||||||
| OrthoDB | EOG42BX7S. | ||||||||||||||||||||||||||||||
| PhylomeDB | P21709. | ||||||||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||||||||
| BRENDA | 2.7.10.1. 2681. | ||||||||||||||||||||||||||||||
| Pathway_Interaction_DB | epha_fwdpathway. EPHA forward signaling. | ||||||||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||||||||
| Bgee | P21709. | ||||||||||||||||||||||||||||||
| CleanEx | HS_EPHA1. | ||||||||||||||||||||||||||||||
| Genevestigator | P21709. | ||||||||||||||||||||||||||||||
| GermOnline | ENSG00000146904. Homo sapiens. | ||||||||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||||||||
| Gene3D | 1.10.150.50. 1 hit. 2.60.40.10. 2 hits. | ||||||||||||||||||||||||||||||
| InterPro | IPR001090. Ephrin_rcpt_lig-bd_dom. IPR003961. Fibronectin_type3. IPR008979. Galactose-bd-like. IPR009030. Growth_fac_rcpt. IPR013783. Ig-like_fold. IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR001660. SAM. IPR013761. SAM/pointed. IPR021129. SAM_type1. IPR001245. Ser-Thr/Tyr_kinase_cat_dom. IPR008266. Tyr_kinase_AS. IPR020635. Tyr_kinase_cat_dom. IPR016257. Tyr_kinase_ephrin_rcpt. IPR001426. Tyr_kinase_rcpt_V_CS. [Graphical view] | ||||||||||||||||||||||||||||||
| Pfam | PF01404. Ephrin_lbd. 1 hit. PF00041. fn3. 2 hits. PF07714. Pkinase_Tyr. 1 hit. PF00536. SAM_1. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| PIRSF | PIRSF000666. TyrPK_ephrin_receptor. 1 hit. | ||||||||||||||||||||||||||||||
| PRINTS | PR00109. TYRKINASE. | ||||||||||||||||||||||||||||||
| SMART | SM00615. EPH_lbd. 1 hit. SM00060. FN3. 2 hits. SM00454. SAM. 1 hit. SM00219. TyrKc. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| SUPFAM | SSF49265. FN_III-like. 2 hits. SSF49785. Gal_bind_like. 1 hit. SSF57184. Grow_fac_recept. 1 hit. SSF56112. Kinase_like. 1 hit. SSF47769. SAM_homology. 1 hit. | ||||||||||||||||||||||||||||||
| PROSITE | PS01186. EGF_2. 1 hit. Uncertain. PS51550. EPH_LBD. 1 hit. PS50853. FN3. 2 hits. PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00109. PROTEIN_KINASE_TYR. 1 hit. PS00790. RECEPTOR_TYR_KIN_V_1. 1 hit. PS00791. RECEPTOR_TYR_KIN_V_2. 1 hit. PS50105. SAM_DOMAIN. 1 hit. [Graphical view] | ||||||||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||||||||
Other | |||||||||||||||||||||||||||||||
| BindingDB | P21709. | ||||||||||||||||||||||||||||||
| ChEMBL | CHEMBL5810. | ||||||||||||||||||||||||||||||
| EvolutionaryTrace | P21709. | ||||||||||||||||||||||||||||||
| GenomeRNAi | 2041. | ||||||||||||||||||||||||||||||
| NextBio | 8291. | ||||||||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||||||||
Entry information
| Entry name | EPHA1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P21709 Secondary accession number(s): A1L3V3, Q15405 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| Human chromosome 7 Human chromosome 7: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
